Global Manufacturing Sun Pharma operates 40 manufacturing facilities across five continents, indicating a broad capacity for scale-up, regional supply presence, and potential for partnerships in multiple geographies to support expansion and tail-end supply services.

R&D Capability With around 2000 research scientists and multiple global R&D centers investing 7-8% of revenues, there are opportunities to position Sun Pharma as a collaborator for early-stage development, API optimization, and next-generation formulations.

Comprehensive Portfolio Manufacturing both pharmaceutical formulations and APIs across over 200 countries suggests potential for cross-sell of integrated API and finished-dose products, as well as contract development and manufacturing (CDMO) arrangements.

Scale and Enterprise A large workforce and high revenue range place Sun Pharma as a target for enterprise-grade procurement solutions, digitalization of supply chain, quality systems, and enterprise software integrations that support global operations.

Technology Footprint Adoption of systems like SAP, TrackWise, IQVIA, and other enterprise tools highlights openness to technology-driven partnerships for data analytics, regulatory compliance, and process optimization across manufacturing and quality workflows.